Navigation Links
Wyeth to Present at the JP Morgan Healthcare Conference
Date:1/8/2009

MADISON, N.J., Jan 8 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) announced today that it will present at the JP Morgan Healthcare Conference on Wednesday, January 14, 2009 at 11:30 a.m. Eastern Time. Presenting for Wyeth will be Geno Germano, President, U.S. and Pharmaceutical Business Units, Wyeth Pharmaceuticals.

Wyeth's presentation will be webcast live for investors at www.wyeth.com and available for replay following the conference.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products, and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.

The statements in this press release that are not historical facts are forward-looking statements based on current expectations of future events that involve risks and uncertainties including, without limitation, risks associated with the inherent uncertainty of the timing and success of pharmaceutical research, product development, manufacturing, commercialization, economic conditions including interest and currency exchange rate fluctuations, changes in generally accepted accounting principles, the impact of competitive or generic products, trade buying patterns, wars or terrorist acts, product liability and other types of lawsuits, the impact of legislation and regulatory compliance and obtaining reimbursement, favorable drug pricing, access and other approvals, environmental liabilities, and patent, and other risks and uncertainties, including those detailed from time to time in the Company's periodic reports, including current reports on Form 8-K, quarterly reports on Form 10-Q and the annual report on Form 10-K, filed with the Securities and Exchange Commission. Actual results may vary materially from the forward-looking statements. The Company assumes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Wyeth
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. SmartOps Enterprise Inventory Optimization Software Licensed by Wyeth Pharmaceuticals
2. Wyeth Announces Positive Data from Phase 2 Study of Neratinib in Advanced HER-2-Positive Breast Cancer
3. Wyeth Sets Webcast and Conference Call for 2008 Fourth Quarter and Full Year Earnings
4. Wyeth to Present at the Credit Suisse Healthcare Conference
5. The Senior Citizens Leagues Comments on U.S. Supreme Court Case Wyeth v. Levine
6. Wyeth v. Levine: Preemption and The Facts
7. Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region
8. Wyeth Selected for 11th Consecutive Year as One of Working Mother Magazines 100 Best Companies for Working Mothers
9. Wyeth Consumer Healthcare Signs Agreement to Purchase ThermaCare from Procter & Gamble
10. Wyeth to Present at the Goldman Sachs Annual Global Healthcare Conference
11. Wyeths Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Segundo, CA (PRWEB) , ... March 23, 2017 ... ... Verisys FACIS Monthly Monitoring Healthcare products at competitive pricing. Verisys ... source sanctions, Exclusions, Debarments, License restrictions and Disciplinary actions. , “We are delighted ...
(Date:3/23/2017)... ... March 23, 2017 , ... On 2 March 2017, the ... Special Operations Command’s Patriot Award. The award was presented by the USSOCOM Commander, ... Foundation for its significant and enduring support to the command. , Accepting ...
(Date:3/23/2017)... ... , ... News Advisory/Interview Opportunity , After six years of advocacy, testimony and ... for public health and the environment and is calling on the United States to ... overwhelming support of European citizens, the European Union (EU) will, beginning next year, ban ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... HealthiPASS, an innovative patient - centric payment system, to expand its focus on ... in the patient financial experience. , “At Ogden Clinic, we are working ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... announced the publication of “Profiling protein expression in circulating tumor cells using microfluidic ... describes the use of the Vortex technology to capture CTCs and ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... , 22 de marzo de 2017   ... líder de soluciones de productos y servicios para ... que ha adquirido EPL Archives, Inc., una organización ... clientes en todo el ciclo de vida de ... una muestra de archivo, almacenamiento de documentos y ...
(Date:3/22/2017)... March 22, 2017 Ampio Pharmaceuticals, Inc. ... of Ampion™, a low molecular weight fraction of ... that it is re-issuing its previous release that was ... disclosures that are required under the NYSE MKT ... these additional disclosures along with the previously disclosed ...
(Date:3/22/2017)... -- New Jersey,s hospitals and ... saved $641 million in healthcare costs between 2012 and ... improvement program. The results reflect five ... of a national initiative from the U.S. Department of ... Hospital Association and its affiliate, the Health Research and ...
Breaking Medicine Technology: